Literature DB >> 24225617

Carbapenem de-escalation therapy in a resource-limited setting.

Anucha Apisarnthanarak1, Nuntanij Bhooanusas, Apiwat Yaprasert, Linda M Mundy.   

Abstract

Pulmonary infection (P=.01) and an infectious diseases consultation (P=.04) were associated with carbapenem de-escalation; pulmonary infection and septic shock were associated with unsuccessful de-escalation. Successful de-escalation was associated with lower mortality (0% vs 23%; P<.001) and shorter duration of carbapenem use (4 vs 10 days; P ≤ .001).

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24225617     DOI: 10.1086/673976

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  5 in total

1.  A retrospective study of antibiotic de-escalation in patients with ventilator-associated pneumonia in Malaysia.

Authors:  Rahela Ambaras Khan; Zoriah Aziz
Journal:  Int J Clin Pharm       Date:  2017-06-22

2.  Meropenem antimicrobial stewardship program: clinical, economic, and antibiotic resistance impact.

Authors:  J F García-Rodríguez; B Bardán-García; M F Peña-Rodríguez; H Álvarez-Díaz; A Mariño-Callejo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-10-26       Impact factor: 3.267

3.  Long-Term Carbapenems Antimicrobial Stewardship Program.

Authors:  José Francisco García-Rodríguez; Belén Bardán-García; Pedro Miguel Juiz-González; Laura Vilariño-Maneiro; Hortensia Álvarez-Díaz; Ana Mariño-Callejo
Journal:  Antibiotics (Basel)       Date:  2020-12-26

4.  Determinants of Deescalation Failure in Critically Ill Patients with Sepsis: A Prospective Cohort Study.

Authors:  Nawal Salahuddin; Lama Amer; Mini Joseph; Alya El Hazmi; Hassan Hawa; Khalid Maghrabi
Journal:  Crit Care Res Pract       Date:  2016-07-14

5.  Impact of Extended and Restricted Antibiotic Deescalation on Mortality.

Authors:  Hwei Lin Teh; Sarimah Abdullah; Anis Kausar Ghazali; Rahela Ambaras Khan; Anitha Ramadas; Chee Loon Leong
Journal:  Antibiotics (Basel)       Date:  2021-12-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.